Private company

Hyundai Bioscience

Hyundai Bioscience is a South Korean company based in North Gyeongsang, founded in 2000.1

현대바이오사이언스(영어: Hyundai Bioscience Co. Ltd.)는 대한민국의 약물전달체(DDS) 기술 전문 회사이다.2 From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2000Founded1
  • HeadquartersNorth Gyeongsang, South Korea1
  • Websitewww.hyundaiibt.com
  • Listed onKorea Exchange (Stock Market)1

Timeline

  1. 2000Founded Founded1

Calendar

Drug trials and FDA: coming up

  1. Jan 2027Phase 2/3 trial readout expected Phase 2/3 trial of CP-COV03 in Dengue: primary completion expected Jan 2027 (ClinicalTrials.gov NCT07576868).3

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar